Glycomet-GP 4 Forte Tablets

Glycomet GP 4 Forte tablets combine Metformin Hydrochloride IP (1000 mg, prolonged-release form) and Glimepiride IP (4 mg) to control blood-glucose levels in adults with Type 2 Diabetes Mellitus.

The dual formula reduces hepatic glucose production and boosts natural insulin release for effective glycemic management.

Manufacturer: USV Private Limited

• Provides dual-action control of high blood sugar.
• Improves insulin sensitivity and glucose utilization.
• Helps reduce long-term diabetes-related complications.
• Once-daily extended-release convenience for better compliance.

• Metformin Hydrochloride IP (Prolonged Release Form): 1000 mg
• Glimepiride IP: 4 mg
• Colour: Red Oxide of Iron
• Excipients: q.s.

As printed on pack: “Each uncoated bilayered tablet contains Metformin Hydrochloride 1000 mg and Glimepiride 4 mg.”

• Use only as directed by your physician.
• Swallow whole with water — do not crush or chew.
• Take with food to minimize stomach upset (if advised).

• Storage: Keep below 30 °C, protected from direct sunlight and moisture.
• Store in a dry, cool place; keep out of reach of children.

• Schedule G & H Prescription Drug: To be sold only on the prescription of a Registered Medical Practitioner.
• Consult your doctor if you have kidney, liver or heart problems before use.
• Monitor blood sugar regularly and follow a balanced diet and exercise plan.

Disclaimer: Information for educational use only. Follow your doctor’s advice. Packaging details may vary per manufacturer batch (USV Pharma).